Alzamend Neuro
NASDAQ: ALZN
Healthcare
Biotechnology
Rank
#43458
Market Cap
3.78 M
Volume
159,614
Price
5.15
Change (%)
13.01%
Country or region
United States
United States
Alzamend Neuro's latest marketcap:
3.78 M
As of May 13, 2025, Alzamend Neuro's market capitalization has reached $3.78 M. According to our data, Alzamend Neuro is the 43458th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.78 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -4,226,937 |
| Shares Out | 733,056 |
| EPS (ttm) | -14.47 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | March 10, 2025 |
Market Cap Chart
Data Updated: May 13, 2025
Alzamend Neuro's yearly market capitalization.
Alzamend Neuro has seen its market value drop from $168.82 M to $3.78 M since 2021, representing a total decrease of 97.76% and an annual compound decline rate (CAGR) of 67.67%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 13, 2025 | $3.78 M | -31.1% |
| December 31, 2024 | $6.30 M | -0.56% |
| December 29, 2023 | $6.34 M | -88.37% |
| December 30, 2022 | $54.47 M | -67.73% |
| December 31, 2021 | $168.82 M |
Company Profile
Frequently Asked Questions
As of May 13, 2025, Alzamend Neuro (including the parent company, if applicable) has an estimated market capitalization of $3.78 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Alzamend Neuro global market capitalization ranking is approximately 43458 as of May 13, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2016 |
| IPO Date | June 15, 2021 |
| Employees | 7 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
